Skip to main content
. 2021 Aug 25;2021(8):CD011564. doi: 10.1002/14651858.CD011564.pub3

IRCT2016020326342N1.

Study name Effectiveness of vitamin D supplementation on severity of cirrhosis based on CHILD and MELD scores in patients with decompensate cirrhosis
Methods Randomised clinical trial using parallel‐group design (2 groups)
Participants Country: Iran
Estimated number of participants: 80
Inclusion criteria: people with HIV, renal failure due to reasons other than liver failure, malabsorption such as chronic diarrhoea, coeliac disease, chronic pancreatitis; people undergoing corticosteroid treatment; pregnancy; and people with cirrhosis secondary to cholestasis such as primary biliary cirrhosis
Interventions Intervention: vitamin D3 (50,000 IU) and popular drugs using for liver cirrhosis
Control: popular drugs using for liver cirrhosis
Daily for 3 months
Outcomes Primary outcome: liver function measured by Model for End‐Stage Liver Disease score
Secondary outcomes: liver function measured by Child‐Turcotte‐Pugh score
Starting date March 2016
Contact information Hossein Ali Abbasi, Emam Reza Hospital, Emam Reza Square, Ebne Sina Avenue, Mashhad, Iran
hoseinabbasi1342@yahoo.com
Notes